Consumer Durables
FUJIFILM Holdings Corp.
In the news
- Fujifilm pictures new pharma-heavy identity with Avigan May 22, 2020
- Avigan trials will continue in Japan, with drug efficacy unclear May 21, 2020
- Fujifilm shares down 5% on negative Avigan report May 20, 2020
- Traditional Chinese cures battle for acceptance in COVID-19 fight May 8, 2020
- No specialist needed: Fujifilm cuts coronavirus test to 75 minutes May 8, 2020 See more articles on FUJIFILM Holdings Corp.
Business Summary
FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Imaging Solutions, Information Solutions, and Document Solutions. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, instant photo systems, etc. The Information Solutions segment deals with the equipment and materials for medical systems, life sciences products, pharmaceuticals, graphic arts, flat panel display materials, recording media and electronic materials, etc. The Document Solutions segment provides office copy machines/MFPs, printers, production systems and services, office services, paper and consumables, etc. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.
Financial Highlights
| Mar 2020 | JPY | USD |
| Revenue | 2,315.14B | 21,293.39M |
| Gross Profit | 954,493M | 8,778.90M |
| Operating income | 186,570M | 1,715.96M |
| Income before tax | 173,071M | 1,591.81M |
| Net income | 124,987M | 1,149.56M |
| EBITDA | 309,223M | 2,844.06M |
| Diluted EPS | 305.22 | 2.80 |
| Dividends Per Share | 95 | 0.87 |
| Total Assets | 3,321.69B | 30,769.22M |
| Total liabilities | 1,327.93B | 12,300.81M |
| Total equity | 1,953.25B | 18,093.20M |
| Operating cash flow | 255,667M | 2,351.48M |
| Currency in JPY | Currency in USD |
Historical Data
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
| Revenue | 2,491.62B | 2,322.16B | 2,433.36B | 2,431.48B | 2,315.14B |
| Gross Profit | 976,632M | 930,644M | 969,096M | 997,516M | 954,493M |
| Operating income | 191,179M | 172,281M | 161,316M | 216,184M | 186,570M |
| Income before tax | 194,529M | 194,775M | 197,807M | 212,762M | 173,071M |
| Net income | 123,313M | 131,506M | 140,694M | 138,106M | 124,987M |
| EBITDA | 312,533M | 289,916M | 288,958M | 346,116M | 309,223M |
| Diluted EPS | 264 | 295.22 | 321.54 | 325.82 | 305.22 |
| Dividends Per Share | 65 | 70 | 75 | 80 | 95 |
| Total Assets | 3,363.67B | 3,533.18B | 3,492.94B | 3,414.69B | 3,321.69B |
| Total liabilities | 1,079.84B | 1,265.13B | 1,194.23B | 1,169.85B | 1,327.93B |
| Total equity | 2,054.45B | 2,043.55B | 2,079.13B | 2,036.96B | 1,953.25B |
| Operating cash flow | 221,869M | 288,619M | 261,152M | 249,343M | 255,667M |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
| Revenue | 20,748.95M | 21,444.42M | 21,955.35M | 21,926.11M | 21,293.39M |
| Gross Profit | 8,132.88M | 8,594.19M | 8,743.79M | 8,995.16M | 8,778.90M |
| Operating income | 1,592.04M | 1,590.95M | 1,455.49M | 1,949.45M | 1,715.96M |
| Income before tax | 1,619.93M | 1,798.68M | 1,784.73M | 1,918.59M | 1,591.81M |
| Net income | 1,026.88M | 1,214.41M | 1,269.43M | 1,245.38M | 1,149.56M |
| EBITDA | 2,602.61M | 2,677.28M | 2,607.16M | 3,121.12M | 2,844.06M |
| Diluted EPS | 2.19 | 2.72 | 2.90 | 2.93 | 2.80 |
| Dividends Per Share | 0.54 | 0.64 | 0.67 | 0.72 | 0.87 |
| Total Assets | 29,927.25M | 31,707.69M | 32,843.81M | 30,850.54M | 30,769.22M |
| Total liabilities | 9,607.56M | 11,353.59M | 11,229.27M | 10,569.19M | 12,300.81M |
| Total equity | 18,278.86M | 18,339.39M | 19,549.91M | 18,403.24M | 18,093.20M |
| Operating cash flow | 1,847.61M | 2,665.30M | 2,356.27M | 2,248.46M | 2,351.48M |
Valuation Measures
| Mar 2020 | |
| PER | 17.76 |
| ROA | 3.71% |
| ROE | 6.26% |
| Operating margin | 8.05% |
| Profit margin | 5.39% |
Key executives
- Chairman & Group Chief Executive Officer: Shigetaka Komori
- President, Group COO & Representative Director: Kenji Sukeno
- Director & Chief Technology Officer: Takashi Iwasaki
- Director & Vice President: Kouichi Tamai
- Executive Officer, Head-Legal Affairs & Audit: Shigeru Sano
Shareholders
- FUJIFILM Holdings Corp. (22.3%)
- Nomura Asset Management Co., Ltd. (4.8%)
- Nippon Life Insurance Co. (3.4%)
- Sumitomo Mitsui Trust Asset Management Co., Ltd. (2.4%)
- Nikko Asset Management Co., Ltd. (2.2%)
- The Vanguard Group, Inc. (2.0%)
- Sumitomo Mitsui Financial Group, Inc. (2.0%)
- Daiwa Asset Management Co. Ltd. (1.9%)
- MS&AD Insurance Group Holdings, Inc. (1.3%)
- BlackRock Fund Advisors (1.1%)
Contact Details
- Website:http://www.fujifilmholdings.com/ja/
- Address: Tokyo Midtown West, 9-7-3 Akasaka, Tokyo, 107-0052, Japan
- Phone: +81.3.6271.1111
Related Companies
- Fujifilm Microdevices Co., Ltd.
- DS Chemport (Australia) Pty Ltd.
- Fujifilm Co., Ltd.
- FX Global Supply Solutions, Inc.
- Fuji Xerox Industry Development (China) Co., Ltd.
- FUJIFILM Printing Plate (China) Co., Ltd.
- FUJIFILM Electronic Materials Korea Co., Ltd.
- Fuji Xerox Eco-Manufacturing (Suzhou) Co., Ltd.
- FUJIFILM Printing Plate Co., Ltd.
- FUJIFILM Hungary Ltd.
- FUJIFILM (Shanghai) Trading Co., Ltd.
- PT Modern Foto
- Fujifilm Electronic Materials Taiwan Co., Ltd.
- Fujitsu General Co, Ltd.
- FUJIFILM Sericol India Pvt Ltd.
- FUJIFILM Italia SpA
- FUJIFILM Hong Kong Ltd.
- FUJIFILM Holdings France SAS
- Fuji Xerox of Shenzhen Ltd.
- Fuji Xerox Industry Development (Shanghai) Co., Ltd.
- Fuji Xerox Far East Ltd.
- FX Global, Inc.
- FUJIFILM (China) Investment Co., Ltd.
- Salmat Asia Ltd.
- Fuji Hunt Photographic Chemicals Pte Ltd.
- Fuji Graphic Systems Canada, Inc.
- FUJIFILM Corp.
- Fuji Xerox Eco-Manufacturing Co., Ltd.
- FUJIFILM Hunt Chemicals Singapore Pte Ltd.
- Fuji Xerox Taiwan Corp.
Competitors
- Canon Inc.
- Eastman Kodak Company
- Xerox Holdings Corporation
- Sindoh Co., Ltd
- Vieworks Co., Ltd
- Hologic, Inc.
- Kinpo Electronics, Inc.
- Mauna Kea Technologies SA Class O
- Charles River Laboratories International, Inc.
- Shenzhen Capchem Technology Co., Ltd. Class A
- EOS Imaging SA
- People & Technology, Inc.
- Uni-Pixel, Inc.
- Sectra AB Class B
- IDEXX Laboratories, Inc.
- Adaptimmune Therapeutics PLC Sponsored ADR
- Binex Co., Ltd
- Biocon Limited
- BioCryst Pharmaceuticals, Inc.
- Check-Cap Ltd.
- Cocrystal Pharma Inc
- Coherus BioSciences, Inc.
- Medtechnica Ltd.
- Motus GI Holdings, Inc.
- Serica Energy PLC
- Cooper Companies, Inc.
- VistaGen Therapeutics, Inc.
Copyright © 2020 FactSet Research Systems Inc. All rights reserved.
Last Updated on 27 May, 2020